A 12 gene prognostic assay that measures gene expression in formalin-fixed paraffin-embedded colon cancer tissue by quantitative reverse transcription-polymerase chain reaction and generates a recurrence score that provides an estimate of the risk of recurrence.
The gene prognostic assay has been validated by 4 large studies.